Abstract
An Israeli cancer diagnostics SME that is developing a cluster of high value novel tumor biomarkers for early detection, prognosis and monitoring of cancer, seeks a partnership with players in the pharmaceutical industry specializing in Oncology Therapeutics to jointly develop companion diagnostics.
Reference Nr 10 IL 80EP 3HP4


